As of 2026-10-15, the Relative Valuation of Talaris Therapeutics Inc (TALS) is (46.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.72 USD, the upside of Talaris Therapeutics Inc based on Relative Valuation is -1817.8%.
The range of the Relative Valuation is (46.50) - (46.85) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.6x - 28.1x | 27.1x |
| Forward P/E multiples | 25.2x - 26.8x | 26.4x |
| Fair Price | (46.50) - (46.85) | (46.72) |
| Upside | -1809.4% - -1822.2% | -1817.8% |
| Date | P/E |